These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 33333417

  • 1. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
    Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R.
    Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
    Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Hojnacki D.
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
    [Abstract] [Full Text] [Related]

  • 3. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis.
    Pol S, Schweser F, Bertolino N, Preda M, Sveinsson M, Sudyn M, Babek N, Zivadinov R.
    Exp Neurol; 2019 Apr; 314():82-90. PubMed ID: 30684521
    [Abstract] [Full Text] [Related]

  • 4. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
    Titelbaum DS, Engisch R, Schwartz ED, Napoli SQ, Sloane JA, Samaan S, Katz JD, Lathi ES.
    J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
    [Abstract] [Full Text] [Related]

  • 5. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
    Tzanetakos D, Tzartos JS, Vakrakou AG, Breza M, Velonakis G, Stathopoulos P, Pantou E, Markakis I, Papadimitriou D, Karavasilis E, Toulas P, Evangelopoulos ΜE, Koutsis G, Anagnostouli M, Stefanis L, Kilidireas C.
    Mult Scler; 2022 Apr; 28(5):718-729. PubMed ID: 34410179
    [Abstract] [Full Text] [Related]

  • 6. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
    Harrison DM, Wang KY, Fiol J, Naunton K, Royal W, Hua J, Izbudak I.
    J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.
    Jonas SN, Izbudak I, Frazier AA, Harrison DM.
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1799-1805. PubMed ID: 30213813
    [Abstract] [Full Text] [Related]

  • 8. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
    Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B, Zivadinov R.
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
    [Abstract] [Full Text] [Related]

  • 9. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    Harrison DM, Allette YM, Zeng Y, Cohen A, Dahal S, Choi S, Zhuo J, Hua J.
    PLoS One; 2024 Apr; 19(5):e0300298. PubMed ID: 38809920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
    Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, Bergsland N, Polak P, Benedict RH, Hojnacki D, Weinstock-Guttman B.
    Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
    Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese IC, Ohayon J, Fenton K, Reyes-Mantilla MI, Maric D, Calabresi PA, Butman JA, Pardo CA, Reich DS.
    Neurology; 2015 Jul 07; 85(1):18-28. PubMed ID: 25888557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.